Pulse Biosciences (PLSE) Accumulated Expenses (2015 - 2025)

Pulse Biosciences' Accumulated Expenses history runs 11 years deep, the most recent figure standing at $2.0 million for Q4 2025.

• On a quarterly basis, Accumulated Expenses fell 71.84% year-over-year to $2.0 million in Q4 2025; TTM through Dec 2025 was $2.0 million, a 71.84% decrease from a year earlier, with the FY2025 full-year figure at $2.0 million, down 71.84% from the prior year.
• Accumulated Expenses declined to $2.0 million in Q4 2025 per PLSE's latest filing, from $4.0 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $7.0 million in Q4 2024 and bottomed at $1.4 million in Q4 2022.
• The 5-year median for Accumulated Expenses is $3.6 million (2021), against an average of $3.5 million.
• Across the five-year window, Accumulated Expenses soared 176.98% in 2023 and plunged 71.84% in 2025, its largest moves.
• Year by year, Accumulated Expenses stood at $3.8 million in 2021, then sank by 63.9% to $1.4 million in 2022, then soared by 176.98% to $3.8 million in 2023, then jumped by 84.24% to $7.0 million in 2024, then plunged by 71.84% to $2.0 million in 2025.
• Per Business Quant, the three latest PLSE Accumulated Expenses figures stand at $2.0 million (Q4 2025), $4.0 million (Q1 2025), and $7.0 million (Q4 2024).